Sequenom Inc (SQNM)

2.36
NASDAQ : Health Care
Prev Close 2.37
Day Low/High 2.36 / 2.37
52 Wk Low/High 0.82 / 2.84
Avg Volume 1.75M
Exchange NASDAQ
Shares Outstanding 119.22M
Market Cap 282.54M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Sequenom Reaches Analyst Target Price

Sequenom Reaches Analyst Target Price

In recent trading, shares of Sequenom Inc have crossed above the average analyst 12-month target price of $1.18, changing hands for $2.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

LabCorp Announces Agreement To Acquire Sequenom

LabCorp Announces Agreement To Acquire Sequenom

Acquisition Creates Market Leader in NIPT, Women's Health and Reproductive Genetics

LabCorp Announces Agreement To Acquire Sequenom

LabCorp Announces Agreement To Acquire Sequenom

Laboratory Corporation of America®  Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare diagnostics company, and Sequenom, Inc.

Insider Trading Alert - KSU, TLMR And SQNM Traded By Insiders

Insider Trading Alert - KSU, TLMR And SQNM Traded By Insiders

Stocks with insider trader activity include KSU, TLMR and SQNM

Sophiris Bio Tops Dollar-Stock Gainers on Trial Success of Cancer Treatment

Shares of the urology company surge in postmarket trading Thursday.

Insider Trading Alert - SQNM, OFIX And CIEN Traded By Insiders

Insider Trading Alert - SQNM, OFIX And CIEN Traded By Insiders

Stocks with insider trader activity include SQNM, OFIX and CIEN

Sequenom Strengthens Executive Team With New Vice President Of Sales

Sequenom Strengthens Executive Team With New Vice President Of Sales

Medical Diagnostics Industry Veteran Will Help Drive Growth of Sequenom Laboratories Tests in New and Existing Channels

Sequenom Announces Contract With Anthem BlueCross

Sequenom Announces Contract With Anthem BlueCross

Agreement covers Noninvasive Prenatal Tests in California

Sequenom Laboratories Announces Positive Results From Clinical Validation Study On The MaterniT® GENOME Test

Sequenom Laboratories Announces Positive Results From Clinical Validation Study On The MaterniT® GENOME Test

Test can detect up to 25% more chromosomal information genome-wide than other leading NIPTs

5 Stocks Insiders Love for 2016

5 Stocks Insiders Love for 2016

Insiders at these companies have been busy buying.